Jump to a section

Sermorelin before and after: the actual changes

Blood-test changes can appear before a visible body change. The human record includes stronger GH responses, changes in selected cognitive tests and early body-composition findings. It also includes unchanged muscle measurements and sleep outcomes. A result needs a specific endpoint: a hormone value, a fat measurement or a performance test.

BLOOD RESULTS

GH and IGF-1

Hormone measurements can change without a visible transformation.

BODY COMPOSITION

Fat and lean tissue

These measurements answer different questions from scale weight.

DAILY PERFORMANCE

Strength and thinking tasks

A gain in one task does not guarantee improvement in every activity.

SLEEP

Mixed outcomes

Individual experiences and objective sleep measurements do not consistently agree.

How long sermorelin takes to show a result

Time pointWhat was assessedWhat it answers
14 daysGH and IGF-1 in older men. [1]An early hormone response.
6 weeksStrength and body composition. [2]Whether function and physical measurements changed together.
5 monthsBody composition and objective sleep. [3]Longer-term measurements in a preliminary report.
6 monthsCognitive testing against placebo. [4]Change in selected mental tasks.

These are assessment points from different studies, not stages everyone passes through. The two-week hormone finding does not promise a two-week change in the mirror. The later body-composition report cannot establish that everyone must continue for five months before deciding whether treatment is worthwhile.

The studies also used different amounts and schedules. A longer study is not proof that duration alone caused the difference. The dosage and cycles article keeps those research schedules separate from lower-dose individual accounts.

A GH response can precede a visible change

In intravenous testing of five healthy men, GH responses peaked at 15 or 30 minutes. [11] That laboratory route does not establish subcutaneous timing. A quick hormone response does not mean immediate muscle growth or fat loss.

GH and IGF-1 changes

Mean IGF-1 rose 33.8% with sermorelin and 0.8% with placebo at six months. [4]

SERMORELIN+33.8%

IGF-1 change.

PLACEBO+0.8%

IGF-1 change.

The starting value changes the absolute meaning of a percentage. An illustrative 30% rise from 100 ng/mL is 30 ng/mL; from 200 ng/mL it is 60 ng/mL. Those examples are arithmetic, not target readings. Neither establishes an amount of new muscle.

Read IGF-1 against the laboratory’s age-adjusted range. Normal IGF-1 does not exclude growth-hormone deficiency, and a low result can have other explanations; stimulation testing may still be needed. [12] Moving from low to normal and moving from normal to high are different outcomes. The largest percentage increase is not automatically the best result.

Ten older men in a separate two-week study had higher GH and IGF-1 on the higher tested schedule. [1] This helps explain why a blood response may precede an appearance change. It does not identify one universal percentage increase for every age, starting level or regimen.

Fat loss and lean-mass results after five months

PRELIMINARY CONFERENCE REPORT · 89 OLDER ADULTS

BODY FAT≈ −6%

Relative decrease.

INTRA-ABDOMINAL FAT≈ −12%

Relative decrease.

LEAN MASS≈ +2%

Relative increase.

These five-month findings were reported in a conference abstract, rather than a full body-composition paper. [3]

Do not subtract six percentage points from a body-fat reading. A relative reduction and a percentage-point reduction are different calculations. Moving from 25% body fat to 19% is a six-point change. The quoted result does not promise that transformation.

For scale, a hypothetical 50 kg of lean mass increased by 2% becomes 51 kg. That is 1 kg in a broad scan category, not proof of 1 kg of new muscle fibers. This arithmetic makes the size of the result easier to understand without turning it into a prediction.

Another hypothetical example: losing 2 kg of fat while gaining 1 kg of lean tissue produces only a 1 kg net weight change. Equal losses and gains could leave weight unchanged. The scale adds everything together; it cannot identify which tissue changed or assign that change to a treatment.

A smaller abdominal-fat measurement also does not tell you how loose skin, bloating or posture changed. Those can alter appearance without the same change in fat. There is no dependable “inches lost per vial” conversion.

Six-week results: some strength gains, unchanged body composition

STRENGTH · BODY COMPOSITION
11 OLDER MEN · SMALL UNCONTROLLED STUDY

Function improved selectively

Two of six strength tests and abdominal endurance improved. Weight, waist-to-hip ratio and scan measurements of muscle and fat did not. [2]

This is a useful answer for someone expecting simultaneous changes in strength, appearance and body weight. The outcomes can disagree. A better lift does not demonstrate hypertrophy, and an unchanged scale does not by itself prove that every other outcome stayed unchanged.

The result also gives no support for predicting a fixed weekly muscle gain. Multiplying a study's average change by more weeks or more peptide assumes a straight-line response that the study did not test.

Sleep results: better nights are not guaranteed

An earlier preliminary analysis found sleep-questionnaire scores changed from 4.1 to 5.41 with treatment and 4.51 to 4.61 with placebo. Higher scores meant poorer sleep; the authors called the change small and its meaning uncertain. [5]

Feeling more rested

A personal experience that can matter in everyday life.

More deep sleep

A specific claim requiring a measurement of sleep stages.

These are different outcomes. An increase in dream recall cannot establish extra deep sleep, and a hormone reading cannot measure how often you woke overnight. The individual accounts below include both better sleep and limited overall benefit.

More rested, without consistently more deep sleep

PUBLIC ACCOUNT · WEARABLE ESTIMATES

At 200 mcg before bed, five days weekly, one person felt more rested and better recovered. Fitbit estimates usually remained at the previous one to one-and-a-half hours of deep sleep. By day five, sleep sometimes worsened and the estimated deep-sleep time fell. Device estimates are not clinical sleep measurements. [10]

Three-month experience: sleep, recovery and higher IGF-1

PUBLIC FIRST-PERSON ACCOUNT · NOT A PRODUCT TESTIMONIAL

SELF-REPORTED IGF-1 · BEFORE181

Reported value; units unstated.

SELF-REPORTED IGF-1 · AFTER317

Reported value around three months.

A 30-year-old powerlifter described better sleep after roughly a week, followed by less soreness and better lifting performance around three months. The account also mentioned temporary warmth, hot flashes and night sweats. The stated nightly volume was 0.3 mL, without a concentration that would establish the microgram amount. [6]

The reported numeric increase is 136, about 75% above the stated starting value. That describes this account; it is not a typical-response estimate. The original post did not provide a controlled comparison or independently verified laboratory records.

A satisfying training result and an out-of-range laboratory result would still need separate judgments. The size of an increase alone does not establish that the final value is desirable for another person.

Four months: better sleep, limited other benefit

MIXED RESPONSE
PUBLIC INDIVIDUAL ACCOUNT

After about four months at 200–300 mcg, sleep improved but other benefits were limited. Increasing to 500–600 mcg added joint pain. Frequency was unstated. A later blood test followed a tesamorelin switch, so its result cannot be assigned to sermorelin. [7]

Seven-month transformation with TRT and sermorelin

PUBLIC COMBINATION ACCOUNT

A 39-year-old posted a seven-month physique comparison while using testosterone and sermorelin. The comments described changing calorie intake, and sermorelin use for four months within that period. The poster said sermorelin did not seem to add much. The stated 0.2 mL volume lacked a concentration. [8]

The visible result

A transformation during a wider training and treatment period.

The missing comparison

The same person on the same plan without sermorelin.

That makes this a combination-treatment example. It is not a clean estimate of sermorelin's contribution. Testosterone, changes in food intake and training all remain part of the account; removing them from the caption would create a different story.

The original photos can be viewed through the source. No substitute transformation image is needed, and a visual change cannot be converted into an exact fat-loss percentage without the relevant measurement.

Sermorelin plus other peptides: the measured hormone result

In a retrospective study of 14 men already on testosterone, sermorelin plus GHRP-2 and GHRP-6 increased mean IGF-1 from 159.5 to 239.0 ng/mL. Average treatment lasted 134 days. Most participants lacked follow-up body measurements. [9]

COMBINATION STUDY · BEFORE159.5

Mean IGF-1, ng/mL.

COMBINATION STUDY · AFTER239.0

Mean IGF-1, ng/mL.

The analysis included men aged 29–39 whose initial IGF-1 was below 200 ng/mL. Only 14 of 105 reviewed patients met its selection requirements, including prescription-refill evidence of adherence. [9] A selected group like this does not supply the average response for everyone buying a sermorelin product.

The difference is 79.5 ng/mL, approximately a 50% increase. It establishes a hormone change for the combination studied. Without separate sermorelin-only and comparison groups, it cannot rank the ingredients or tell you how much muscle each contributed.

Six-month results on a cognitive test

Mean performance-IQ scores: sermorelin 114.68 → 119.02; placebo 115.22 → 116.60. [4]

GroupChange in score
Sermorelin+4.34 points
Placebo+1.38 points

The difference in change was 2.96 points. This does not represent a percentage increase in intelligence.

The benefits article explains the cognitive claim alongside the separate muscle, fat and sleep findings.

THE PRACTICAL QUESTIONS

Questions & answers.

How quickly will I see sermorelin results?

Hormone responses and visible changes have different timelines. Research has assessed hormones after two weeks and other outcomes over several months. Those assessment dates do not establish a personal deadline for fat loss or muscle gain.

How much weight can I lose with sermorelin?

The available results do not supply a dependable number of pounds per month. Fat measurements, lean mass and scale weight can change differently. A relative reduction in fat is not the same percentage reduction in body weight.

Can results appear before the first month?

An individual account described earlier sleep improvement, but this is not an established response schedule. A blood change, dream recall and a visible change in body composition are separate outcomes.

Does feeling nothing mean sermorelin is not working?

A biological response may not produce a noticeable sensation. Feeling nothing also does not prove that a product is active. A specific treatment goal and relevant clinical measurements are more informative than chasing an immediate feeling.

Will a larger amount produce faster results?

There is no reliable straight-line conversion from a larger amount to faster fat loss, better sleep or more muscle. Increasing treatment can add unwanted effects without improving the intended outcome.

Do the results last after stopping?

A measurement taken during treatment cannot establish how much benefit remains months after stopping. The cited findings do not provide a reliable retention percentage or a universal maintenance schedule.

Can before-and-after photos prove sermorelin worked?

They can show an appearance change. They cannot isolate sermorelin when testosterone, other peptides, food intake and training also changed, or measure visceral fat from the outside.

Sources & batch documents12 references · expand to read
  1. Corpas et al. Fourteen-day GHRH(1–29) study in older men: GH and IGF-1 response, 1992. ↗
  2. Vittone et al. Six weeks of nightly GHRH(1–29) in 11 older men: selected strength gains, unchanged body composition, 1997. ↗
  3. Vitiello et al. Five-month sermorelin study. Sleep 2003, abstract 0384.H, page A154. Preliminary body-composition and objective sleep results. ↗
  4. Vitiello et al. Six-month controlled sermorelin cognition study, 2006. Table 2 and hormone results. ↗
  5. Vitiello et al. Investigators’ preliminary sleep-questionnaire results, 2001. ↗
  6. Original first-person account: sleep, training recovery and self-reported IGF-1 after roughly three months. ↗
  7. Original first-person account: about four months, improved sleep, limited other benefit and joint pain with higher amounts. Later testing followed a switch. ↗
  8. Original seven-month physique post and author comments: TRT, sermorelin, calorie changes and limited perceived added sermorelin benefit. ↗
  9. Sigalos et al. Sermorelin/GHRP-2/GHRP-6 in 14 men on testosterone. Retrospective hormone results, 2017. ↗
  10. Original first-person account: 200 mcg, perceived restfulness and mixed Fitbit deep-sleep estimates. ↗
  11. Barron et al. GHRH(1–29)-NH2 responses after intravenous dosing in five healthy men, 1985. ↗
  12. Endocrine Society. Adult growth-hormone deficiency guideline: age-adjusted IGF-1 interpretation and diagnostic testing, 2011. ↗